Search Results
ChemoSymposium 2011: PARP treatment for BRCA mutated and triple negative breast cancer
ASCO 2009: PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer
Dr. Lori Pierce on the Impact of BRCA1/2 Mutations on Breast Cancer Treatment Decisions
PARP Inhibition in Breast Cancer Part 1 of 2
PARP Inhibition in Breast Cancer Part 2 of 2
PARP Inhibitors for Cancer Treatment - Part3
BRCA1 gene and breast cancer discussed on ABC4
ESMO 2014: Inhibition of PARP, angiogenesis and immune checkpoints for ovarian cancer management
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response
Breast cancer: Potential new treatment for aggressive form of the cancer
PARP Inhibitors
ECCO 2017 - A New PARP Inhibitor to Clinical Practice - Part 3
